Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Abcellera Biologics Inc. (ABCL) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Abcellera Biologics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1703057.
Total stock buying since 2020: $88,420,376.
Total stock sales since 2020: $372,352,284.
Total stock option exercises since 2020: $27,080,863.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 428,631 | $940,321 | 0 | $0 | 0 | $0 |
| 2024 | 283,516 | $739,976 | 0 | $0 | 420,084 | $924,888 |
| 2023 | 267,500 | $1,613,438 | 0 | $0 | 474,500 | $653,648 |
| 2022 | 2,437,203 | $17,374,637 | 0 | $0 | 274,500 | $615,648 |
| 2021 | 363,398 | $5,308,704 | 15,198,420 | $372,352,284 | 4,736,166 | $24,797,579 |
| 2020 | 3,122,165 | $62,443,300 | 0 | $0 | 270,000 | $89,100 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-03 | 428,631 | $940,321 | 0 | $0 | 0 | $0 |
| 2024-11 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2024-09 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2024-08 | 283,516 | $739,976 | 0 | $0 | 0 | $0 |
| 2024-06 | 0 | $0 | 0 | $0 | 83,334 | $15,666 |
| 2024-05 | 0 | $0 | 0 | $0 | 168,375 | $454,611 |
| 2024-02 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2023-11 | 30,000 | $137,400 | 0 | $0 | 56,125 | $151,537 |
| 2023-09 | 40,000 | $202,000 | 0 | $0 | 0 | $0 |
| 2023-08 | 30,000 | $177,000 | 0 | $0 | 56,125 | $151,537 |
| 2023-05 | 167,500 | $1,097,038 | 0 | $0 | 306,125 | $199,037 |
| 2023-02 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2022-12 | 85,102 | $859,274 | 0 | $0 | 50,000 | $9,500 |
| 2022-11 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2022-08 | 200,000 | $2,292,400 | 0 | $0 | 56,125 | $151,537 |
| 2022-06 | 128,633 | $998,877 | 0 | $0 | 0 | $0 |
| 2022-05 | 1,993,468 | $12,957,687 | 0 | $0 | 56,125 | $151,537 |
| 2022-03 | 30,000 | $266,399 | 0 | $0 | 0 | $0 |
| 2022-02 | 0 | $0 | 0 | $0 | 56,125 | $151,537 |
| 2021-12 | 86,938 | $1,218,870 | 0 | $0 | 750,000 | $207,500 |
| 2021-11 | 270,460 | $3,986,454 | 0 | $0 | 307,833 | $4,620,896 |
| 2021-09 | 0 | $0 | 137,351 | $2,325,352 | 1,145,000 | $19,565,850 |
| 2021-08 | 6,000 | $103,380 | 162,649 | $2,756,900 | 0 | $0 |
| 2021-06 | 0 | $0 | 14,898,420 | $367,270,032 | 1,533,333 | $369,333 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-11 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 343,631 | 2.16 | 742,242 |
| 2025-03-10 | Montalbano John S. (Director) | Buy | 25,000 | 2.30 | 57,499 |
| 2025-03-06 | Montalbano John S. (Director) | Buy | 60,000 | 2.34 | 140,580 |
| 2024-11-25 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2024-09-20 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2024-08-29 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 283,516 | 2.61 | 739,976 |
| 2024-06-21 | Lecault Veronique (Chief Operating Officer) | Option Ex | 83,334 | .19 | 15,666 |
| 2024-05-31 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 112,250 | 2.70 | 303,074 |
| 2024-02-26 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2023-11-23 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2023-11-08 | Montalbano John S. (Director) | Buy | 10,000 | 4.46 | 44,600 |
| 2023-11-06 | Montalbano John S. (Director) | Buy | 20,000 | 4.64 | 92,800 |
| 2023-09-22 | Hayden Michael R (Director) | Buy | 20,000 | 4.91 | 98,200 |
| 2023-09-12 | Lecault Veronique (Chief Operating Officer) | Buy | 20,000 | 5.19 | 103,800 |
| 2023-08-24 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2023-08-08 | Hayden Michael R (Director) | Buy | 30,000 | 5.90 | 177,000 |
| 2023-05-26 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 153,000 | 6.52 | 997,713 |
| 2023-05-26 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2023-05-26 | Booth Andrew (Chief Financial Officer) | Buy | 14,500 | 6.85 | 99,325 |
| 2023-05-05 | Lecault Veronique (Chief Operating Officer) | Option Ex | 250,000 | .19 | 47,500 |
| 2023-02-22 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2022-12-20 | Booth Andrew (Chief Financial Officer) | Option Ex | 50,000 | .19 | 9,500 |
| 2022-12-16 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 85,102 | 10.10 | 859,274 |
| 2022-11-18 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2022-08-19 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 200,000 | 11.46 | 2,292,400 |
| 2022-08-18 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2022-06-14 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 9,173 | 8.05 | 73,842 |
| 2022-06-13 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 54,915 | 8.03 | 441,077 |
| 2022-06-06 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 64,545 | 7.50 | 483,958 |
| 2022-05-18 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2022-05-16 | Lecault Veronique (Chief Operating Officer) | Buy | 200,000 | 6.34 | 1,267,800 |
| 2022-05-13 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 300,000 | 7.25 | 2,176,500 |
| 2022-05-12 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 1,408,468 | 6.41 | 9,021,237 |
| 2022-05-12 | Booth Andrew (Chief Financial Officer) | Buy | 85,000 | 5.79 | 492,150 |
| 2022-03-04 | Montalbano John S. (Director) | Buy | 10,000 | 8.54 | 85,399 |
| 2022-03-01 | Montalbano John S. (Director) | Buy | 20,000 | 9.05 | 181,000 |
| 2022-02-22 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 56,125 | 2.70 | 151,537 |
| 2021-12-10 | Booth Andrew (Chief Financial Officer) | Option Ex | 500,000 | .32 | 160,000 |
| 2021-12-08 | Lecault Veronique (Chief Operating Officer) | Option Ex | 250,000 | .19 | 47,500 |
| 2021-12-03 | Lo Andrew (Director) | Buy | 86,938 | 14.02 | 1,218,870 |
| 2021-11-30 | Lecault Veronique (Chief Operating Officer) | Option Ex | 83,333 | 14.96 | 1,246,661 |
| 2021-11-18 | Hansen Carl L. G. (Chief Executive Officer) | Option Ex | 224,500 | 15.03 | 3,374,235 |
| 2021-11-11 | Thermopylae Holdings Ltd. (10% Owner) | Buy | 202,960 | 14.76 | 2,995,892 |
| 2021-11-11 | Booth Andrew (Chief Financial Officer) | Buy | 67,500 | 14.68 | 990,562 |
| 2021-09-13 | Hayden Michael R (Director) | Option Ex | 270,000 | 17.73 | 4,787,100 |
| 2021-09-01 | Falconer Ester (Chief Technology Officer) | Option Ex | 875,000 | 16.89 | 14,778,750 |
| 2021-09-01 | Hamer John (Director) | Sale | 137,351 | 16.93 | 2,325,352 |
| 2021-08-31 | Hamer John (Director) | Sale | 162,649 | 16.95 | 2,756,900 |
| 2021-08-16 | Montalbano John S. (Director) | Buy | 6,000 | 17.23 | 103,380 |
| 2021-06-22 | Hayden Michael R (Director) | Sale | 100,000 | 25.50 | 2,550,000 |
| 2021-06-15 | Lecault Veronique (Chief Operating Officer) | Option Ex | 333,333 | .19 | 63,333 |
| 2021-06-09 | Falconer Ester (Chief Technology Officer) | Sale | 1,000,000 | 25.50 | 25,500,000 |
| 2021-06-09 | Thermopylae Holdings Ltd. (10% Owner) | Sale | 5,598,420 | 24.03 | 134,530,032 |
| 2021-06-09 | Lecault Veronique (Chief Operating Officer) | Sale | 1,000,000 | 25.50 | 25,500,000 |
| 2021-06-09 | Hansen Carl L. G. (Chief Executive Officer) | Sale | 6,000,000 | 24.77 | 148,590,000 |
| 2021-06-09 | Booth Andrew (Chief Financial Officer) | Sale | 1,200,000 | 25.50 | 30,600,000 |
| 2021-06-07 | Booth Andrew (Chief Financial Officer) | Option Ex | 1,200,000 | .26 | 306,000 |
| 2021-03-19 | Falconer Ester (Chief Technology Officer) | Option Ex | 1,000,000 | .03 | 34,000 |
| 2020-12-15 | Stimart Tryn (Chief Legal Officer) | Buy | 500 | 20.00 | 10,000 |
| 2020-12-15 | Montalbano John S. (Director) | Buy | 25,000 | 20.00 | 500,000 |
| 2020-12-15 | Lecault Veronique (Chief Operating Officer) | Buy | 23,000 | 20.00 | 460,000 |
| 2020-12-15 | Hayden Michael R (Director) | Buy | 73,665 | 20.00 | 1,473,300 |
| 2020-12-15 | Thiel Peter (Director) | Buy | 3,000,000 | 20.00 | 60,000,000 |
| 2020-11-06 | Hayden Michael R (Director) | Option Ex | 270,000 | .33 | 89,100 |
Insider trading activities including stock purchases, stock sales, and option exercises of ABCL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Abcellera Biologics Inc. (symbol ABCL, CIK number 1703057) see the Securities and Exchange Commission (SEC) website.